PUBLISHER: Grand View Research | PRODUCT CODE: 1553961
PUBLISHER: Grand View Research | PRODUCT CODE: 1553961
The global sustainable pharmaceutical packaging market size was estimated at USD 87.24 billion in 2023 and is expected to grow at a CAGR of 14.2% from 2024 to 2030. The market is driven by several key factors, reflecting a growing awareness of environmental issues and regulatory pressures. One of the primary drivers is the increasing focus on reducing plastic waste and carbon footprint across industries, including pharmaceuticals. This has led to a surge in demand for eco-friendly packaging materials such as biodegradable plastics, recycled paper, and plant-based alternatives.
In addition, regulatory changes and government initiatives are crucial in shaping the sustainable pharmaceutical packaging landscape. Many countries have implemented stricter regulations on single-use plastics and are encouraging the use of recyclable materials. For instance, the European Union's Circular Economy Action Plan aims to make all packaging reusable or recyclable by 2030, pushing pharmaceutical companies to innovate their packaging designs. This has led to the development of solutions like blister packs made from mono-materials that are easier to recycle.
Consumer awareness and preferences are another significant driving factor for the market. As patients become more environmentally conscious, there's a growing demand for pharmaceuticals packaged in sustainable materials. This trend pushes companies to adopt greener packaging and communicate their sustainability efforts to consumers.
Major companies in the market are undertaking multiple strategic initiatives to enhance their competitive position and capitalize on market opportunities. These strategies include launching new products, engaging in mergers and acquisitions, forming partnerships & collaborations, and expanding into new geographic regions. For instance, in February 2024, Sanofi Consumer Healthcare joined the Blister Pack Collective, formed by PA Consulting and PulPac, to develop recyclable fiber-based blister packs to reduce plastic waste in pharmaceutical packaging. The initiative seeks to replace problematic plastics like PVC, which contribute to the 100,000 tonnes of plastic used annually in medical packaging, with PulPac's Dry Molded Fiber technology, which boasts an 80% lower CO2 footprint than traditional materials. Hence, this strategic decision was intended to enhance the sustainability of its packaging product and inspire industry-wide changes towards environmentally friendly packaging solutions.
Global Sustainable Pharmaceutical Packaging Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global sustainable pharmaceutical packaging market report based on material, product, process, and region: